348 related articles for article (PubMed ID: 30057278)
1. The 2018 Revision to the Process of Care Model for Management of Erectile Dysfunction.
Mulhall JP; Giraldi A; Hackett G; Hellstrom WJG; Jannini EA; Rubio-Aurioles E; Trost L; Hassan TA
J Sex Med; 2018 Oct; 15(10):1434-1445. PubMed ID: 30057278
[TBL] [Abstract][Full Text] [Related]
2. The 2018 Revision to the Process of Care Model for Evaluation of Erectile Dysfunction.
Mulhall JP; Giraldi A; Hackett G; Hellstrom WJG; Jannini EA; Rubio-Aurioles E; Trost L; Hassan TA
J Sex Med; 2018 Sep; 15(9):1280-1292. PubMed ID: 30057280
[TBL] [Abstract][Full Text] [Related]
3. An Evaluation of a Clinical Care Pathway for the Management of Men With Nonorganic Erectile Dysfunction.
Jenkins LC; Hall M; Deveci S; Guhring P; Parker M; Nelson CJ; Mulhall JP
J Sex Med; 2019 Oct; 16(10):1541-1546. PubMed ID: 31444103
[TBL] [Abstract][Full Text] [Related]
4. SOP conservative (medical and mechanical) treatment of erectile dysfunction.
Porst H; Burnett A; Brock G; Ghanem H; Giuliano F; Glina S; Hellstrom W; Martin-Morales A; Salonia A; Sharlip I;
J Sex Med; 2013 Jan; 10(1):130-71. PubMed ID: 23343170
[TBL] [Abstract][Full Text] [Related]
5. Update on the Safety of Phosphodiesterase Type 5 Inhibitors for the Treatment of Erectile Dysfunction.
Yafi FA; Sharlip ID; Becher EF
Sex Med Rev; 2018 Apr; 6(2):242-252. PubMed ID: 28923561
[TBL] [Abstract][Full Text] [Related]
6. Erectile Dysfunction Treatment Following Radical Cystoprostatectomy: Analysis of a Nationwide Insurance Claims Database.
Chappidi MR; Kates M; Sopko NA; Joice GA; Tosoian JJ; Pierorazio PM; Bivalacqua TJ
J Sex Med; 2017 Jun; 14(6):810-817. PubMed ID: 28460994
[TBL] [Abstract][Full Text] [Related]
7. Impact of a first treatment with phosphodiesterase inhibitors on men and partners' quality of sexual life: results of a prospective study in primary care.
Costa P; Grandmottet G; Mai HD; Droupy S
J Sex Med; 2013 Jul; 10(7):1850-60. PubMed ID: 23679019
[TBL] [Abstract][Full Text] [Related]
8. The second Princeton consensus on sexual dysfunction and cardiac risk: new guidelines for sexual medicine.
Jackson G; Rosen RC; Kloner RA; Kostis JB
J Sex Med; 2006 Jan; 3(1):28-36; discussion 36. PubMed ID: 16409215
[TBL] [Abstract][Full Text] [Related]
9. Potential for Long-Term Benefit of Cognitive Behavioral Therapy as an Adjunct Treatment for Men with Erectile Dysfunction.
Khan S; Amjad A; Rowland D
J Sex Med; 2019 Feb; 16(2):300-306. PubMed ID: 30770073
[TBL] [Abstract][Full Text] [Related]
10. Erectile Dysfunction Medications and Treatment for Cardiometabolic Risk Factors: A Pharmacoepidemiologic Study.
Skeldon SC; Cheng L; Morgan SG; Detsky AS; Goldenberg SL; Law MR
J Sex Med; 2017 Dec; 14(12):1597-1605. PubMed ID: 29198514
[TBL] [Abstract][Full Text] [Related]
11. Erectile Dysfunction: An Umbrella Review of Meta-Analyses of Risk-Factors, Treatment, and Prevalence Outcomes.
Allen MS; Walter EE
J Sex Med; 2019 Apr; 16(4):531-541. PubMed ID: 30833150
[TBL] [Abstract][Full Text] [Related]
12. The effect of lifestyle modification and cardiovascular risk factor reduction on erectile dysfunction: a systematic review and meta-analysis.
Gupta BP; Murad MH; Clifton MM; Prokop L; Nehra A; Kopecky SL
Arch Intern Med; 2011 Nov; 171(20):1797-803. PubMed ID: 21911624
[TBL] [Abstract][Full Text] [Related]
13. Erectile dysfunction diagnosis and treatment as a means to improve medication adherence and optimize comorbidity management.
Scranton RE; Goldstein I; Stecher VJ
J Sex Med; 2013 Feb; 10(2):551-61. PubMed ID: 23153075
[TBL] [Abstract][Full Text] [Related]
14. Core document on erectile dysfunction: key aspects in the care of a patient with erectile dysfunction.
Brotons FB; Campos JC; Gonzalez-Correales R; Martín-Morales A; Moncada I; Pomerol JM
Int J Impot Res; 2004 Oct; 16 Suppl 2():S26-39. PubMed ID: 15496854
[TBL] [Abstract][Full Text] [Related]
15. Erectile dysfunction and diabetes: a review of the current evidence-based medicine and a synthesis of the main available therapies.
Phé V; Rouprêt M
Diabetes Metab; 2012 Feb; 38(1):1-13. PubMed ID: 22056307
[TBL] [Abstract][Full Text] [Related]
16. Undertreatment of erectile dysfunction: claims analysis of 6.2 million patients.
Frederick LR; Cakir OO; Arora H; Helfand BT; McVary KT
J Sex Med; 2014 Oct; 11(10):2546-53. PubMed ID: 25059314
[TBL] [Abstract][Full Text] [Related]
17. Relationship between age and erectile dysfunction diagnosis or treatment using real-world observational data in the USA.
Mulhall JP; Luo X; Zou KH; Stecher V; Galaznik A
Int J Clin Pract; 2016 Dec; 70(12):1012-1018. PubMed ID: 28032424
[TBL] [Abstract][Full Text] [Related]
18. Coronary Heart Disease, Diabetes, and Sexuality in Men.
Hackett G; Krychman M; Baldwin D; Bennett N; El-Zawahry A; Graziottin A; Lukasiewicz M; McVary K; Sato Y; Incrocci L
J Sex Med; 2016 Jun; 13(6):887-904. PubMed ID: 27215685
[TBL] [Abstract][Full Text] [Related]
19. Cardiovascular Outcome Risks in Patients With Erectile Dysfunction Co-Prescribed a Phosphodiesterase Type 5 Inhibitor (PDE5i) and a Nitrate: A Retrospective Observational Study Using Electronic Health Record Data in the United States.
Nunes AP; Seeger JD; Stewart A; Gupta A; McGraw T
J Sex Med; 2021 Sep; 18(9):1511-1523. PubMed ID: 34389264
[TBL] [Abstract][Full Text] [Related]
20. Two Birds with One Stone: Regular Use of PDE5 Inhibitors for Treating Male Patients with Erectile Dysfunction and Cardiovascular Diseases.
Cai Z; Zhang J; Li H
Cardiovasc Drugs Ther; 2019 Feb; 33(1):119-128. PubMed ID: 30675707
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
